Suha Alsubaihi
The University of Jordan (UJ) officially launched the Medication Safety (SAFE-MED) research group as part of its continued commitment to advancing excellence in applied health sciences and reinforcing its leadership in scientific research. The initiative aligns with the University’s strategic vision to promote high-quality research, enhance healthcare systems, and foster evidence-based innovation.
SAFE-MED aims to develop advanced scientific measures in medication safety, strengthen pharmacovigilance and safe prescribing practices, and improve the quality of medication use to reduce medication-related harm. The group’s work contributes directly to several United Nations Sustainable Development Goals (SDGs), particularly Good Health and Well-being, Reduced Inequalities, Industry, Innovation and Infrastructure, Quality Education, and Partnerships for the Goals.
The group’s research agenda addresses a wide range of priority areas, including adverse drug reactions, immunosuppressive therapies, psychotropic medications and antidepressants, complementary and alternative medicine, polypharmacy, medication safety among the elderly, the impact of medications on driving performance, cytotoxicity of emerging therapies, pharmacogenetics, and pharmacovigilance systems.
The research group comprises distinguished scholars from the University of Jordan, including Prof. Nailya Bulatova and Prof. Almotassem Yousef from the Department of Biopharmaceutics and Clinical Pharmacy at the School of Pharmacy, Prof. Akram Saleh from the Department of Internal Medicine at the School of Medicine, Prof. Violet Kasabri and Prof. Abla Mahmoud Albsoul from the Department of Biopharmaceutics and Clinical Pharmacy at the School of Pharmacy, Dr. Maysa Suyagh from the same department, and PhD candidate Noor Faeq Mamdooh from the Department of Pharmaceutical Sciences at the School of Pharmacy.
The group also includes international collaborators and industry representation, namely Prof. Thaqif El Khassawna from the Experimental Trauma Surgery Medical Research Group at Justus Liebig University Giessen in Germany, Dr. Mohammed Zawiah from the Department of Clinical Practice at the College of Pharmacy, Northern Border University in Rafha, Saudi Arabia, and Batool AlKhawaldeh, a representative of the Jordan Pharmacists Association affiliated with NEX – Next Evolution in Excellence and the Pharmacy Pioneering Initiative in Jordan.
SAFE-MED places strong emphasis on building strategic partnerships with academic, healthcare, and industrial institutions at both the national and international levels. It also actively engages graduate students in high-impact research projects, contributing to the development of the next generation of pharmacists, physicians, and health researchers in Jordan.
The establishment of the SAFE-MED research group is expected to enhance the quality of healthcare services locally and internationally and further consolidate the University of Jordan’s standing as a leading academic and research institution in medication safety and applied health sciences.
For more information, please visit the Medication Safety (SAFE-MED) group page on the University of Jordan’s research portal.